<DOC>
	<DOCNO>NCT02382224</DOCNO>
	<brief_summary>The purpose study examine efficacy worry exposure intervention , form cognitive behavioral therapy ( CBT ) , comparison waitlist condition treatment Generalized Anxiety Disorder . There total 60 subject enrol University Texas Austin . Patients randomize ( like flip coin ) either 12-sessions WE therapy 12-week waitlist offer entry therapy .</brief_summary>
	<brief_title>Worry Exposure Generalized Anxiety Disorder</brief_title>
	<detailed_description>This application propose randomize controlled trial , aim examine efficacy worry exposure ( WE ) intervention treatment generalize anxiety disorder ( GAD ) . This protocol base GAD treatment manual first test Germany . It translate English , version yet test . A grow body research call development novel intervention individual GAD . GAD chronic debilitate condition high rate recurrence , lifetime prevalence 5.7 % . Although efficacious psychological intervention exist , many either receiving intervention remain highly symptomatic follow termination intervention . More specifically , cognitive behavioral therapy ( CBT ) empirically support treatment GAD . However , many patient relapse continue experience significant symptom treatment . Up 57 % patient meet criterion high endstate functioning CBT . Together , finding call development better intervention efficacious easy disseminate . The core symptom GAD persistent uncontrollable worry , allow individual way cognitively avoid perceive threat emotionally dangerous situation . One study examine efficacy WE alone , applied relaxation ( AR ) alone , WL control group , find WE effective treatment GAD , conclude WE develop . Given area avoidance patient GAD , author recommend add vivo exposure future trial . The present application propose test WE addition vivo exposure United States effective treatment GAD . The present study involve randomization 60 adult GAD either ( 1 ) 12-sessions WE therapy ( 2 ) 12-week waitlist ( WL ) , enter therapy . The author hypothesize participant WE intervention evidence great reduction anxiety symptom severity measure quality life relative individual randomize WL .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<criteria>18 65 year age principal diagnosis Generalized Anxiety Disorder willing capable providing informed consent , attend study visit , comply protocol current diagnosis psychotic , developmental , bipolar disorder significant suicide risk determine structure interview psychoactive substance dependence within past 3 month Inability communicate English limit mental competency inability give inform , voluntary , write consent participate psychotropic medication acceptable stabilize least 3 week prior baseline visit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>generalize anxiety disorder</keyword>
	<keyword>anxiety</keyword>
	<keyword>worry exposure</keyword>
	<keyword>treatment</keyword>
</DOC>